SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-227389
Filing Date
2021-07-28
Accepted
2021-07-28 16:09:30
Documents
90
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d145126d10q.htm   iXBRL 10-Q 3255243
2 EX-31.1 d145126dex311.htm EX-31.1 10344
3 EX-31.2 d145126dex312.htm EX-31.2 10329
4 EX-32 d145126dex32.htm EX-32 4307
  Complete submission text file 0001193125-21-227389.txt   12359233

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20210630.xsd EX-101.SCH 74020
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20210630_cal.xml EX-101.CAL 45467
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20210630_def.xml EX-101.DEF 505733
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20210630_lab.xml EX-101.LAB 520931
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20210630_pre.xml EX-101.PRE 540258
10 EXTRACTED XBRL INSTANCE DOCUMENT d145126d10q_htm.xml XML 2723175
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 211122631
SIC: 2834 Pharmaceutical Preparations